CD19 and acute lymphoblastic leukemia: Acute Lymphoblastic Leukemia (ALL) is a hematological tumor arising from lymphoid progenitor cells of B-lineage or T-lineage [1], which due to abnormal growth of CD19+ precursor B cells and subsequent inhibition of normal hematopoiesis, resulting in anemia, thrombocytopenia, and neutropenia [2].